Tamoxifen Versus Etoposide After First Recurrence in GBM Patients
Status:
Not yet recruiting
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
The investigator propose a single-center randomized phase II controlled study designed to
compare the management of first recurrence of GBM using etoposide versus tamoxifen.